infohep news

• Treatment for people who use drugs

  People who inject drugs have a high hepatitis C cure rate despite imperfect adherence

  Liz Highleyman / 15 November 2018

  Most people who inject drugs completed treatment with sofosbuvir/velpatasvir (Epclusa) and achieved sustained virological response (SVR) in a real-world setting, even if they had interruptions in therapy, according to a presentation at the AASLD ...

• Pan-genotypic regimens

  8 weeks of Maviret cures 98% of people with hepatitis C and cirrhosis

  Keith Alcorn / 14 November 2018

  An 8-week course of the combination of glecaprevir and pibrentasvir (Maviret) is highly effective in curing hepatitis C in people with compensated cirrhosis, across a wide range of genotypes, Robert S. Brown of ...

• Hepatocellular carcinoma (HCC)

  Aspirin use associated with lower risk of liver cancer

  Liz Highleyman / 13 November 2018

  Taking aspirin about twice a week for five years or more may reduce the risk of developing hepatocellular carcinoma (HCC) by about half, according to research presented this week at the AASLD Liver ...

• Treatment outcomes

  Sofosbuvir/ledipasvir cures most young children with hepatitis C

  Liz Highleyman / 13 November 2018

  Almost all young children ages 3 to 6 years with chronic hepatitis C achieved sustained virological response after 12 weeks of treatment using sofosbuvir/ledipasvir oral granules, according to findings presented at the ...

• Sexual transmission

  Hepatitis C is detectable in rectal and nasal fluid

  Keith Alcorn / 12 November 2018

  High levels of hepatitis C virus (HCV) can be found in the rectal and nasal fluids of people with high hepatitis C viral loads even when blood is not present, Austrian researchers ...